2009 Press Releases

Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash    
Life Technologies Corporation (NASDAQ:LIFE) today announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation (NYSE:DHR) for $450 million in cash.

DHR to Acquire Life Sciences Instrumentation Businesses from MDS Inc. and Life Technologies Corp.     
Danaher Corporation (NYSE: DHR) today announced that it has signed a definitive agreement with MDS Inc. (TSX: MDS; NYSE: MDZ) to acquire the Analytical Technologies division of MDS, which includes a 50% ownership position in Applied Biosystems/MDS Sciex joint venture ("SCIEX"), a mass spectrometry business, and a 100% ownership position in the former Molecular Devices Corporation, a bioresearch and analytical instrumentation company.

Applied Biosystems and Chromsystems Team Up to Simplify Mass Spectrometry for Clinical Research    
Applied Biosystems, part of Life Technologies Corporation (NASDAQ: LIFE), and Chromsystems Instruments & Chemicals GmbH today announced joint solutions for the clinical research field.

Applied Biosystems Partners With China to Help Reinforce New Standards for Food Safety   
Applied Biosystems, part of Life Technologies Corporation (NASDAQ: LIFE), today announced that it is assisting the Chinese government in reinforcing new standards for food safety in China.

French Researchers Accelerate Biomarker Research With QTRAP^®5500 Mass Spectrometry Systems     
Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced that scientists at bioMérieux, a world leader in the field of in vitro diagnostics, and the Institute of Analytical Sciences of the University of Lyon in France are collaborating on research to advance the discovery of biomarkers that can be used to diagnose or monitor disease.

Applied Biosystems Expands Portfolio of Services to Support Mass Spectrometry Workflows
Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced a set of new services offered through its Global Services organization to better support its mass spectrometry customers.

Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometry Tools to Advance Public Health and Safety
Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), today announced the commercial availability of new mass spectrometry tools to help laboratories in a variety of industries advance their efforts to improve public health and safety.

Applied Biosystems/MDS Analytical Technologies Accelerates Productivity for Drug Development and Clinical Research With New Mass Spectrometry Solution
Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDSAnalytical Technologies, a business  unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), today announced the launch of Cliquid^® MPX^TM-2 high-throughput workflow, an end-to-end solution for mass spectrometry users to accelerate productivity for pharmaceutical and clinical research.

Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometer to Accelerate Proteomics Research
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), today introduced the SCIEX TOF/TOF(TM) 5800 System, the fastest, most sensitive MALDI-based mass spectrometer ever built.

Applied Biosystems/MDS Analytical Technologies SCIEX QTRAP 5500 Mass Spectrometry System Earns Scientists' Choice Award from SelectScience
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), today announced that the SCIEX QTRAP^® 5500 System, a unique, next-generation mass spectrometer, has received theScientists' Choice Award for Best New Spectroscopy Product by SelectScience.net, a leading online resource for applied chemists, clinical chemists and life scientists.

Applied Biosystems/MDS Analytical Technologies Launch New Test Methods to Simplify Mass Spectrometry Applications
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (TSX:MDS)(NYSE:MDZ), today announced the commercial availability of a new suite of test methods that simplify the use of mass spectrometry technology for food and water quality testing, forensic toxicology and clinical research.

Everglades Environmental Restoration Project Aided by Mass Spectrometry Solution From Applied Biosystems/MDS Analytical Technologies  
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), today announced that scientists at Jupiter Environmental Laboratories in Florida are using a mass spectrometry solution to support the environmental restoration of the once pristine waterways of the Florida Everglades.